Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Wednesday, August 5, 2009

Genzyme’s blood cancer treatment lands European approval

By Mass High Tech staff

Cambridge biotechnology giant Genzyme Corp. has been granted approval from the European Commission to market its Mozobil treatment of blood cancers. The treatment is expected to provide a new option for patients with lymphoma and multiple myeloma in need of an autologous stem cell transplant.

Currently in orphan drug status in both the U.S. and the European Union, Mozobil is designed to work in combination with granulocyte-colony stimulating factor (G-CSF) to improve stem cell collection for transplantation in those patients with blood cancers who may have poor cell mobilization. The process of collecting enough stem cells for transplant can take several hours over several days, according to the company.

Genzyme officials noted in a statement that the treatment can reduce costs for transplant centers by improving efficiency and predicted outcomes, as well as reduce the number of patients who require a second mobilization procedure.

Genzyme (Nasdaq: GENZ) launched Mozobil in Mexico in April, and it is currently seeking marketing approval in Argentina, Australia, Brazil, Israel and Singapore.

Founded in 1981, Genzyme is a global biotech firm focused on rare inherited disorders, kidney disease, cancer, transplant and immune disease and diagnostic testing.



 

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Comments

Please Login/Register to post comments.

No comments have been added or approved.

On the MHT blog now

Flagsuit wins another NASA Astronaut Glove Challenge

Southwest Harbor, Maine's Peter Homer won $450,000 in NASA's Astronaut Glove Challenge yesterday. This is Homer's second time winning the contest. Homer's first win in 2007 launched his startup, Flagsuit. Flagsuit is developing pressure suits using the same technology as Homer's prizewinning gloves -- for use as a wearable substitute for hyperbaric chambers used to treat conditions such as ...

Read More

Boston University - MS MBA
Most Popular Stories
EmailedViewed
Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
FinanceFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of, registration on, this site constitutes acceptance of our User Agreement. Please read our Privacy Policy (updated) A publishing partner with Portfolio